However, the tumor microenvironment poses challenges, as cancer cells often exhibit an elevated expression of co-inhibitory protein ligands, including CD80/86 and programmed death-ligand 1 (PD-L1) [19,20,21]. This evidence concerns the gene CD80 and neoplasm.